FDA
-
-
-
-
-
-
-
Homology Medicines Announces FDA Lifted Clinical Hold on pheNIX Gene Therapy Trial for PKU
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FAT, Cano, Vertiv, and Homology and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Homology Medicines (FIXX) PT Lowered to $4 at Stifel on Lack of Visibility into Clinical Hold Resolution, Awaits More Specific Updates
-
-
-
-
-
-
-
Homology Medicines Initiates Clinical Trial for HMI-203, a One-Time Investigational Gene Therapy Candidate for Adults with MPS II (Hunter Syndrome)
-
-
-
-
-
-
-
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU
-
-
-
-
-
-
-
Lyra Therapeutics Appoints Bradford Smith to its Board of Directors
-
-
-
-
-
-
-
Homology Medicines Reports First Quarter 2019 Financial Results and Recent Highlights
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

